Bill > SP0476

This joint resolution designates May 4, 2025 to May 10, 2025 as Tardive Dyskinesia (TD) Awareness Week, drawing attention to an important neurological condition associated with long-term antipsychotic medication use. The resolution highlights that approximately 800,000 adults in the United States live with TD, with about 60% remaining undiagnosed, and that the condition involves uncontrollable, abnormal movements affecting various body parts. It notes that certain populations, including individuals over 55, Black individuals, women, and those with mood or substance use disorders, are at higher risk. The resolution emphasizes the importance of routine TD screening as recommended by the American Psychiatric Association and acknowledges that FDA-approved treatments can help manage symptoms and improve quality of life. By designating this awareness week, the legislature aims to encourage education and screening for healthcare providers, patients, and care partners, with the goal of promoting early detection, intervention, and support for individuals experiencing this challenging neurological condition.

https://legislature.maine.gov/legis/bills/display_ps.asp?paper=SP0476&snum=132